Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$293K Hold
2,118
0.13% 114
2015
Q2
$325K Hold
2,118
0.13% 117
2015
Q1
$339K Hold
2,118
0.14% 121
2014
Q4
$338K Sell
2,118
-63
-3% -$9.82K 0.14% 124
2014
Q3
$306K Sell
2,181
-255
-10% -$33.3K 0.12% 133
2014
Q2
$289K Sell
2,436
-2,280
-48% -$264K 0.1% 147
2014
Q1
$581K Sell
4,716
-2,240
-32% -$272K 0.22% 97
2013
Q4
$793K Sell
6,956
-382
-5% -$43.5K 0.3% 83
2013
Q3
$821K Buy
7,338
+63
+0.9% +$6.83K 0.35% 76
2013
Q2
$717K Buy
+7,275
New +$755K 0.32% 79

Other funds holding AMGN

Argent Trust Company's AMGN Position: Q3 2015 in Review

Argent Trust Company held its Amgen (AMGN) position steady in Q3 2015 at 2,118 shares worth $293K. The position accounts for 0.13% of the portfolio, ranked #114.

Argent Trust Company first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $821K in Q3 2013. 1,381 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Argent Trust Company held 2,118 shares of Amgen worth $293K as of Q3 2015.
  • Argent Trust Company left its Amgen share count unchanged in Q3 2015.
  • Amgen made up 0.13% of Argent Trust Company's portfolio in Q3 2015, its #114 holding.
  • Argent Trust Company first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • Argent Trust Company's Amgen position peaked at $821K in Q3 2013.
  • 1,381 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.